全球軌道植入物市場：COVID-19 的增長、趨勢、影響和預測（2022-2027 年）

Eye Socket Implant Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: 2022年01月17日 | 出版商:

Mordor Intelligence Pvt Ltd | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全貌
簡介
目錄

簡介

全球眼眶植入物市場預計在預測期內的複合年增長率為 6.7%。

推動市場增長的主要因素包括青光眼和白內障等眼病的流行，以及公司和其他與眼病相關的組織發起的宣傳活動。

本報告對全球眼眶植入物市場進行調查，提供市場概況、市場增長和製約因素分析、按產品類型/應用/地區、競爭形勢和主要公司分析。提供全面的信息，例如.

The Eye Socket Implant Market is expected to register a CAGR of 6.7% during the forecast period owing to the higher prevalence of eye diseases such as glaucoma, cataract, etc. A cataract is an eye disease that is usually characterized by clouding of the lens, the severity of which may further lead to vision impairment. According to the World Health Organization, around 65.2 million people suffered from cataracts in 2019. Furthermore, awareness campaigns organized by companies and other organizations related to eye diseases is expected to drive the market growth. For instance, in 2019, Allergan in association with Glaucoma Research Foundation (GRF) initiated a campaign "My Glaucoma" to grow awareness among people about the burden of glaucoma and its treatment. Hence, such initiatives are expected to impact positively on the eye socket implants market.

Key Market Trends

Glaucoma Segment is Expected to Hold a Major Market Share in the Eye Socket Implant Market

* Glaucoma is expected to be a dominant segment in the eye socket implant market due to the higher prevalence and aging population. According to the World Health Organization, in 2019, approximately 6.9 million people worldwide were diagnosed with glaucoma.

* It is one of the major reasons for preventable vision impairment. Approximately 1 billion people suffer from blindness due to unaddressed glaucoma. Also, diabetic people are at high risk of causing glaucoma. According to the Centre for Disease Control and Prevention, in 2019, around 7.1 % of the population diagnosed with diabetes aged 45 years and above had glaucoma too.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global eye socket implant market due to the growing aging population and associated eye disorders. According to Centre for Disease Control and Prevention, in 2019, the population aged over 45 years, suffering from diabetes, also suffered from cataracts with a prevalence of around 32.2%, 8.6% with diabetic retinopathy and 4.3% had macular degeneration in the United States. Furthermore, increasing product approvals related to eye socket implants is expected to fuel market growth. For instance, in 2019, Alcon received a US FDA (Food & Drug Administration) approval for AcrySof IQ PanOptix Trifocal IOL, a trifocal lens for intermediate and distance vision.

Competitive Landscape

Companies are taking initiatives in order to improve their presence in the market. For instance, in 2019, Alcon acquired Power Vision, Inc., a company dedicated to manufacturing fluid-based intraocular lens implants to extend its product line for eye socket implants. Some of the companies which are currently dominating the market are Carl Zeiss, Alcon, BVI (Physiol), AJL Ophthalmic SA (Addition Technology Inc.), Gulden Ophthalmics, Bausch & Lomb, FCI, Aurolab, Morcher GmbH and Staar Surgical

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Growing Burden of Eye Diseases
- 4.2.2 Rising Technological Advancements
4.3 Market Restraints
- 4.3.1 High Cost of Implants
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type
- 5.1.1 Glaucoma Implant
- 5.1.2 Corneal Implant
- 5.1.3 Intraocular Lens
- 5.1.4 Others
5.2 By Application
- 5.2.1 Glaucoma
- 5.2.2 Age-related Maccular Degenration
- 5.2.3 Diabetic Retinopathy
- 5.2.4 Others
5.3 Geography
- 5.3.1 North America
  - 5.3.1.1 United States
  - 5.3.1.2 Canada
  - 5.3.1.3 Mexico
- 5.3.2 Europe
  - 5.3.2.1 Germany
  - 5.3.2.2 United Kingdom
  - 5.3.2.3 France
  - 5.3.2.4 Italy
  - 5.3.2.5 Spain
  - 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
  - 5.3.3.1 China
  - 5.3.3.2 Japan
  - 5.3.3.3 India
  - 5.3.3.4 Australia
  - 5.3.3.5 South Korea
  - 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
  - 5.3.4.1 GCC
  - 5.3.4.2 South Africa
  - 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
  - 5.3.5.1 Brazil
  - 5.3.5.2 Argentina
  - 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
- 6.1.1 AJL Ophthalmic SA (Addition Technology Inc.)
- 6.1.2 Alcon
- 6.1.3 Aurolab
- 6.1.4 Bausch & Lomb
- 6.1.5 BVI (Physiol)
- 6.1.6 Carl Zeiss
- 6.1.7 Gulden Ophthalmics
- 6.1.8 Johnson & Johnson
- 6.1.9 Morcher GmbH
- 6.1.10 Staar Surgical